Clinical Characteristics and Survival Analysis of Breast Cancer Molecular Subtypes with Hepatic Metastases |
Ge, Qi-Dong
(Department of Breast Oncology, Sun Yat-sen University Cancer Center)
Lv, Ning (Department of Breast Oncology, Sun Yat-sen University Cancer Center) Kong, Ya-Nan (Department of Breast Oncology, Sun Yat-sen University Cancer Center) Xie, Xin-Hua (Department of Breast Oncology, Sun Yat-sen University Cancer Center) He, Ni (State Key Laboratory of Oncology in South China) Xie, Xiao-Ming (Department of Breast Oncology, Sun Yat-sen University Cancer Center) Wei, Wei-Dong (Department of Breast Oncology, Sun Yat-sen University Cancer Center) |
1 | Cheang MC, Voduc D, Bajdik C, et al (2008). Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res, 14, 1368-76. DOI |
2 | Early Breast Cancer Trialists' Collaborative Group (2005). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet, 365, 1687-717. DOI |
3 | Fan C, Oh DS, Wessels L, et al (2006). Concordance among gene-expression-based predictors for breast cancer. N Engl J Med, 355, 560-9. DOI |
4 | Harrell JC, Prat A, Parker JS, et al (2012). Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse. Breast Cancer Res Treat, 132, 523-35. DOI |
5 | Hoe AL, Royle GT, Taylor I (1991). Breast liver metastases--incidence, diagnosis and outcome. J R Soc Med, 84, 714-6. |
6 | Hu Z, Fan C, Oh DS, et al (2006). The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics, 7, 96. DOI |
7 | Miller KD, Sledge GW Jr (1999). The role of chemotherapy for metastatic breast cancer. Hematol Oncol Clin North Am, 13, 415-34. DOI |
8 | Nielsen TO, Hsu FD, Jensen K, et al (2004). Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res, 10, 5367-74. DOI ScienceOn |
9 | O'Reilly SM, Richards MA, Rubens RD (1990). Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival. Eur J Cancer, 26, 574-7. DOI |
10 | Parker JS, Mullins M, Cheang MC, et al (2009). Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol, 27, 1160-7. DOI |
11 | Patanaphan V, Salazar OM, Risco R (1988). Breast cancer: metastatic patterns and their prognosis. South Med J, 81, 1109-12. DOI |
12 | Perou CM, Sorlie T, Eisen MB, et al (2000). Molecular portraits of human breast tumours. Nature, 406, 747-52. DOI ScienceOn |
13 | Shibuya K, Mathers CD, Boschi-Pinto C, et al (2002). Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer, 2, 37. DOI |
14 | Sinn HP, Helmchen B, Wittekind CH (2010). [TNM classification of breast cancer: changes and comments on the 7th edition]. Pathologe, 31, 361-6. DOI |
15 | Sorlie T, Perou CM, Tibshirani R, et al (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A, 98, 10869-74. DOI ScienceOn |
16 | Sorlie T, Tibshirani R, Parker J, et al (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A, 100, 8418-23. DOI |
17 | Wyld L, Gutteridge E, Pinder SE, et al (2003). Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer, 89, 284-90. DOI ScienceOn |
18 | Zinser JW, Hortobagyi GN, Buzdar AU, et al (1987). Clinical course of breast cancer patients with liver metastases. J Clin Oncol, 5, 773-82. |